Skip to main content
Clinical Trials/NCT02379819
NCT02379819CompletedNot Applicable

Nucleus Hybrid L24 Implant System: New Enrollment Study

Cochlear19 sites in 1 country52 target enrollmentStarted: February 1, 2015Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Cochlear
Enrollment
52
Locations
19
Primary Endpoint
Change in Consonant-Nucleus-Consonant (CNC) Word Recognition in Quiet for the Two Listening Conditions: Implant Ear Alone and When Using Both Ears Together From Pre-operatively Through 3 Years Post-activation of the Device

Study Overview

Brief Summary

This study evaluates the long term safety and effectiveness of the Nucleus Hybrid L24 Implant in a group of newly implanted adults.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Ear to Be Implanted:
  • •Normal to moderate hearing loss in the low frequencies with severe to profound mid to high frequency hearing loss in the ear to be implanted
  • •CNC word recognition of 10-60% in the ear to be implanted
  • •Contralateral Ear:
  • •Moderately severe to profound mid to high frequency hearing loss in the contralateral ear
  • •CNC word recognition equal to or better than that in the ear to be implanted but not more than 80% correct

Exclusion Criteria

  • •not proficient in English
  • •unwilling and/or unable to comply with the test protocol
  • •deafness due to lesions of the acoustic nerve or central auditory pathway.
  • •active middle-ear disease, with or without tympanic membrane perforation.
  • •absence of cochlear development.
  • •duration of severe to profound hearing loss of 30 years or greater

Arms & Interventions

Nucleus Hybrid L24 Implant

Experimental

Adults age 18 and over who meet FDA criteria for unilateral implantation with the Nucleus Hybrid L24 Implant.

Intervention: Nucleus Hybrid L24 Implant (Device)

Outcomes

Primary Outcomes

Change in Consonant-Nucleus-Consonant (CNC) Word Recognition in Quiet for the Two Listening Conditions: Implant Ear Alone and When Using Both Ears Together From Pre-operatively Through 3 Years Post-activation of the Device

Time Frame: From pre-operatively through 3 years post-activation of the device

The CNC Words test consists of 10 recorded lists of 50 monosyllabic words in CD format. For this study, two lists will be administered in quiet at a level equal to 60 dBA in the sound field and recorded as a total number of words correct, which will be expressed as a percentage correct for this study. The CNC word test has a score range of 0-100% with higher values indicating better scores.

Number of Device or Procedure Related Adverse Events

Time Frame: Up to 5 years post-activation of the device

Secondary Outcomes

  • Change in AzBio Sentence Recognition in Noise in the Best Unilateral Condition(Pre-operatively, up to 3 years post-activation of the device)

Investigators

Sponsor
Cochlear
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (19)

Loading locations...

Similar Trials

Hybrid L24 New Enrollment Post Approval... | Clinical Trial